BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18022638)

  • 1. Structural implications of Siglec-5-mediated sialoglycan recognition.
    Zhuravleva MA; Trandem K; Sun PD
    J Mol Biol; 2008 Jan; 375(2):437-47. PubMed ID: 18022638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolded recombinant Siglec5 for NMR investigation of complex carbohydrate binding.
    Barb AW; Wang X; Prestegard JH
    Protein Expr Purif; 2013 Apr; 88(2):183-9. PubMed ID: 23321067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family.
    Alphey MS; Attrill H; Crocker PR; van Aalten DM
    J Biol Chem; 2003 Jan; 278(5):3372-7. PubMed ID: 12438315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
    Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
    J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
    Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
    J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
    Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
    Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
    J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
    Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
    J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.
    Angata T; Varki A
    Glycobiology; 2000 Apr; 10(4):431-8. PubMed ID: 10764831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
    Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
    Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
    Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
    Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b.
    Attrill H; Imamura A; Sharma RS; Kiso M; Crocker PR; van Aalten DM
    J Biol Chem; 2006 Oct; 281(43):32774-83. PubMed ID: 16895906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
    Bochner BS
    Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
    Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
    FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions.
    Connolly NP; Jones M; Watt SM
    Br J Haematol; 2002 Oct; 119(1):221-38. PubMed ID: 12358929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.